Book a session to
try SightPlus™
The life-changing device that helped thousands of people like Maisy McAdam to see clearly again.
Book a session to
try SightPlus™
The life-changing device that helped thousands of people like Maisy McAdam to see clearly again.
"It was overwhelming. He was flabbergasted. He just could not believe that he was able to see things that he had not been able to see before."

(Helen, Charlie's Mom)
Hundreds of patients have taken SightPlus™ home and many have lived with it for years. Learn about their experiences
Photo by Jacob
Photo by Jacob
Find more stories
Introducing the Next Generation
of Wearable Vision Aids
We are looking for early adopters and testers to pilot our new device. If you would like to shape our next generation product features, or get an early access to the product, we want to hear from you.
Introducing the Next Generation
of Wearable Vision Aids
We are looking for early adopters and testers to pilot our new device. If you would like to shape our next generation product features, or get an early access to the product, we want to hear from you.
Clinical Evidence
1,100
patients have taken part in trials since 2015.
67%
achieved 0.2 logMar (20/20 vision) or better irrespective of baseline BCVA.
97%
patients improved sight by 30 EDTRS (6 lines on the sight chart) or higher.
88%
are still using device regularly with 41% using it every single day.
Clinical Evidence
1,100
patients have taken part in trials since 2015.
67%
achieved 0.2 logMar (20/20 vision) or better irrespective of baseline BCVA.
97%
patients improved sight by 30 EDTRS (6 lines on the sight chart) or higher.
88%
are still using device regularly with 41% using it every single day.
Show more
Our Supporters: